Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Treatment of Alcohol Use Disorder
NCT05988632Phase 2Recruiting
- Sponsor
- Brown University
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Generex Oral-lyn in alcohol use disorder (AUD), sponsored by Brown University. Started Feb 2025; status: recruiting.
02
Drugs
Generex Oral-lyn
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05988632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05988632.